Back to Results
First PageMeta Content
Hepatitis / HIV/AIDS / Viruses / Viral hepatitis / Hepatitis C / Needle-exchange programme / World Hepatitis Day / HIV prevention / Hepatitis B / Health / Medicine / Biology


POLICY BRIEF ON HEPATITIS C INFECTION AMONG INJECTING DRUG USERS Xavier Majó Roca, Catalunya Ministry of Health, Programme on Substance Abuse
Add to Reading List

Document Date: 2014-12-06 09:29:50


Open Document

File Size: 366,54 KB

Share Result on Facebook

City

Stockholm / L. A. / Amsterdam / Geneva / London / Brussels / Edinburgh / /

Company

McDonald SA / Guideline Management / Member States / Harm Reduction Consulting Services Inc. / Lok A. S. / Curr Pharm / New England Journal / Heroin Networks / Eurasian Harm Reduction Network / /

Continent

Europe / /

Country

Scotland / Belgium / /

Currency

USD / /

Event

FDA Phase / Business Partnership / /

Facility

National Institute / Hall AJ / /

IndustryTerm

Treatment of Hepatitis C / Prevention of HBV / HIV prevention / Prevention of Hepatitis C / pharmaceutical industry representatives / Therapy For Hepatitis C / drug care services / surveillance systems / reduction services / HCV treatment / healthcare costs / drug users social networks / Hepatitis C Treatment / injection equipment / needed prevention information services / HCV prevention / government health care systems / expert / treatment services / vaccination services / Treatment for Hepatitis C / hepatitis prevention / /

MarketIndex

TA 75 / /

MedicalCondition

viral hepatitis B / HIV / HBV / moderate chronic hepatitis C / cirrhosis / hepatitis B / HIV infections / drug-related blood-borne infectious diseases / Hepatitis / Illness / chronic HCV infection / liver disease / HCV liver disease / HCV / C infection / chronic infections / HCV infection / Initial infection / epidemic levels / Why HCV infection / Virus Infection / Swiss Hepatitis C / AIDS / HIV/AIDS / infection / viral hepatitis / chronic hepatitis / chronic infection / TB / viral hepatitis infections / epidemic / hepatitis C / caused hepatitis / mild disease / MS / enhanced hepatitis / Infections / heroin users / disease / reverse HIV epidemics / viral hepatitis epidemics / Mild Chronic Hepatitis C46 / Mild Chronic Hepatitis C / Clinical Infectious Diseases / liver cancer / infectious diseases / Inc. EXECUTIVE SUMMARY INTRODUCTION Hepatitis C / infection diseases / HCV disease / good Hepatitis C / /

MedicalTreatment

nutritional support / vaccination / Antiviral Therapies / liver transplants / Clinical Protocol / counseling / counselling / vaccinations / drug therapy / /

Organization

World Health Organization / National Institute for Health and Clinical Excellence of the United Kingdom / UNODC / World Hepatitis Alliance / European Parliament / Global Fund / World Health Organisation / Civil Society / European Centre for Disease Prevention and Control / European Commission / European Union / European Society for the Study of the Liver / UNAIDS / Ministry of Health / Advisory Council of the Misuse of Drugs / Scottish Government / Council of the European Union / European Liver Patient Association / World Health Assembly / Home Office / /

Person

Andrea Wittecka / Graham R. Foster / Jason Glanz / Peter Vickerman / David J. Goldberg / Patrick Schmida / Katharina Hensel-Kochb / Matthew Hickman / Judd A. Hickman / Natasha K. Martin / Anna Baron / Sharon J. Hutchinson / Stephen Koester / Eberhard Schatz / Dasha Ocheret / Xavier Majó Roca / Baldo V / Maria C. Thurnheerc / Philip Bruggmannd / /

Position

D. J. / advocate / Editor / Governor / /

Product

ribavirin / sterile water / WHO European / WHO European Region / /

PublishedMedium

American Journal of Public Health / New England Journal of Medicine / Clinical Infectious Diseases / /

RadioStation

Wait / WHA / /

Region

New England / Central Europe / Eastern Europe / /

Technology

pdf / http / /

URL

www.jhep-elsevier.com/article/S0168-8278 / http /

SocialTag